Sentinel Lymph Node Mapping in Melanoma in the Twenty-first Century

被引：12

作者：

Doepker, Matthew P. ^{[1
]}

Zager, Jonathan S. ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2015年 / 24卷 / 02期

关键词：

Sentinel lymph node biopsy; Lymphoscintigraphy; Melanoma; Thin; Thick; Desmoplastic; CUTANEOUS MELANOMA; DESMOPLASTIC MELANOMA; THIN MELANOMA; PROGNOSTIC-FACTORS; METASTATIC MELANOMA; MALIGNANT-MELANOMA; EXTREMITY MELANOMA; GROIN DISSECTION; MITOTIC RATE; BLUE-DYE;

D O I：

10.1016/j.soc.2014.12.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The incidence of melanoma is increasing faster than any other cancer. The status of the regional nodal basin remains the most important prognostic factor. Sentinel lymph node biopsy (SLNB) is recommended for staging in patients diagnosed with intermediate-thickness melanoma (1.01-4.0 mm). SLNB is considered somewhat controversial, especially when used to stage thin (1 mm), thick (>4 mm), or desmoplastic melanoma. This article reviews the current literature regarding SLNB in thin, intermediate, thick, and desmoplastic melanoma. Data supporting the use of newer radiopharmaceuticals in sentinel lymph node mapping along with newer imaging modalities are also reviewed.

引用

页码：249 / +

页数：13

共 65 条

[1]

[Anonymous], J CLIN ONCOLOGY S

[2]

[Anonymous], 2019, CLIN PRACTICE GUIDEL

[3]

BAAS PC, 1992, ARCH SURG-CHICAGO, V127, P281

[4] Final Version of 2009 AJCC Melanoma Staging and Classification [J].

Balch, Charles M. ;

Gershenwald, Jeffrey E. ;

Soong, Seng-jaw ;

Thompson, John F. ;

Atkins, Michael B. ;

Byrd, David R. ;

Buzaid, Antonio C. ;

Cochran, Alistair J. ;

Coit, Daniel G. ;

Ding, Shouluan ;

Eggermont, Alexander M. ;

Flaherty, Keith T. ;

Gimotty, Phyllis A. ;

Kirkwood, John M. ;

McMasters, Kelly M. ;

Mihm, Martin C., Jr. ;

Morton, Donald L. ;

Ross, Merrick I. ;

Sober, Arthur J. ;

Sondak, Vernon K. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6199-6206

[5] Efficacy of Repeat Sentinel Lymph Node Biopsy in Patients Who Develop Recurrent Melanoma [J].

Beasley, Georgia M. ;

Speicher, Paul ;

Sharma, Ketan ;

Seigler, Hilliard ;

Salama, April ;

Mosca, Paul ;

Tyler, Douglas S. .

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 218 (04) :686-692

[6] Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas [J].

Bleicher, RJ ;

Essner, R ;

Foshag, LJ ;

Wanek, LA ;

Morton, DL .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) :1326-1331

[7] Cutaneous desmop astic melanoma - Reappraisal of morphologic heterogeneity and prognostic factors [J].

Busam, KJ ;

Mujumdar, U ;

Hummer, AJ ;

Nobrega, J ;

Hawkins, WG ;

Coit, DG ;

Brady, MS .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (11) :1518-1525

[8] Regional recurrence after negative sentinel lymph node biopsy for melanoma [J].

Carlson, Grant W. ;

Page, Andrew J. ;

Cohen, Cynthia ;

Parker, Douglas ;

Yaar, Ron ;

Li, Anya ;

Hestley, Andrea ;

Delman, Keith A. ;

Murray, Douglas R. .

ANNALS OF SURGERY, 2008, 248 (03) :378-385

[9]

CASCINELLI N, 1986, EUR J SURG ONCOL, V12, P175

[10] Sentinel lymph node biopsy for head and neck melanomas [J].

Chao, C ;

Wong, SL ;

Edwards, MJ ;

Ross, MI ;

Reintgen, DS ;

Noyes, RD ;

Stadelmann, WK ;

Lentsch, E ;

McMasters, KM .

ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) :21-26

← 1 2 3 4 5 6 7 →